BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31068442)

  • 1. Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections.
    Bakowski MA; Shiroodi RK; Liu R; Olejniczak J; Yang B; Gagaring K; Guo H; White PM; Chappell L; Debec A; Landmann F; Dubben B; Lenz F; Struever D; Ehrens A; Frohberger SJ; Sjoberg H; Pionnier N; Murphy E; Archer J; Steven A; Chunda VC; Fombad FF; Chounna PW; Njouendou AJ; Metuge HM; Ndzeshang BL; Gandjui NV; Akumtoh DN; Kwenti TDB; Woods AK; Joseph SB; Hull MV; Xiong W; Kuhen KL; Taylor MJ; Wanji S; Turner JD; Hübner MP; Hoerauf A; Chatterjee AK; Roland J; Tremblay MS; Schultz PG; Sullivan W; Chu XJ; Petrassi HM; McNamara CW
    Sci Transl Med; 2019 May; 11(491):. PubMed ID: 31068442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird models.
    Hübner MP; Gunderson E; Vogel I; Bulman CA; Lim KC; Koschel M; Ehrens A; Frohberger SJ; Fendler M; Tricoche N; Voronin D; Steven A; Chi V; Bakowski MA; Woods AK; Petrassi HM; McNamara CW; Beerntsen B; Chappell L; Sullivan W; Taylor MJ; Turner JD; Hoerauf A; Lustigman S; Sakanari JA
    Int J Parasitol Drugs Drug Resist; 2020 Apr; 12():18-27. PubMed ID: 31869759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.
    Aljayyoussi G; Tyrer HE; Ford L; Sjoberg H; Pionnier N; Waterhouse D; Davies J; Gamble J; Metuge H; Cook DAN; Steven A; Sharma R; Guimaraes AF; Clare RH; Cassidy A; Johnston KL; Myhill L; Hayward L; Wanji S; Turner JD; Taylor MJ; Ward SA
    Sci Rep; 2017 Mar; 7(1):210. PubMed ID: 28303006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections.
    Schiefer A; Hübner MP; Krome A; Lämmer C; Ehrens A; Aden T; Koschel M; Neufeld H; Chaverra-Muñoz L; Jansen R; Kehraus S; König GM; Pogorevc D; Müller R; Stadler M; Hüttel S; Hesterkamp T; Wagner K; Pfarr K; Hoerauf A
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008930. PubMed ID: 33284808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis.
    Ehrens A; Lunde CS; Jacobs RT; Struever D; Koschel M; Frohberger SJ; Lenz F; Fendler M; Turner JD; Ward SA; Taylor MJ; Freund YR; Stefanakis R; Easom E; Li X; Plattner JJ; Hoerauf A; Hübner MP
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007957. PubMed ID: 31986143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy in murine filariasis (Litomosoides sigmodontis): comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability.
    Volkmann L; Fischer K; Taylor M; Hoerauf A
    Trop Med Int Health; 2003 May; 8(5):392-401. PubMed ID: 12753632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wolbachia in filarial nematodes: evolutionary aspects and implications for the pathogenesis and treatment of filarial diseases.
    Bandi C; Trees AJ; Brattig NW
    Vet Parasitol; 2001 Jul; 98(1-3):215-38. PubMed ID: 11516587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wolbachia bacteria of filarial nematodes: a target for control?
    Taylor MJ; Bandi C; Hoerauf AM; Lazdins J
    Parasitol Today; 2000 May; 16(5):179-80. PubMed ID: 10782070
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi.
    Townson S; Hutton D; Siemienska J; Hollick L; Scanlon T; Tagboto SK; Taylor MJ
    Ann Trop Med Parasitol; 2000 Dec; 94(8):801-16. PubMed ID: 11214099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Litomosoides sigmodontis: vaccine-induced immune responses against Wolbachia surface protein can enhance the survival of filarial nematodes during primary infection.
    Lamb TJ; Harris A; Le Goff L; Read AF; Allen JE
    Exp Parasitol; 2008 Feb; 118(2):285-9. PubMed ID: 17919582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of a filarial phosphate permease that is up-regulated in response to depletion of essential Wolbachia endobacteria.
    Arumugam S; Hoerauf A; Pfarr KM
    Exp Parasitol; 2014 Mar; 138():30-9. PubMed ID: 24480589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wolbachia endosymbionts and human disease control.
    Slatko BE; Luck AN; Dobson SL; Foster JM
    Mol Biochem Parasitol; 2014 Jul; 195(2):88-95. PubMed ID: 25046729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential display of genes expressed in the filarial nematode Litomosoides sigmodontis reveals a putative phosphate permease up-regulated after depletion of Wolbachia endobacteria.
    Heider U; Blaxter M; Hoerauf A; Pfarr KM
    Int J Med Microbiol; 2006 Aug; 296(4-5):287-99. PubMed ID: 16616613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of Wolbachia from Brugia pahangi is closely linked to worm death and fecundity but does not result in altered lymphatic lesion formation in Mongolian gerbils (Meriones unguiculatus).
    Chirgwin SR; Coleman SU; Porthouse KH; Nowling JM; Punkosdy GA; Klei TR
    Infect Immun; 2003 Dec; 71(12):6986-94. PubMed ID: 14638788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wolbachia endosymbiotic bacteria of filarial nematodes. A new insight into disease pathogenesis and control.
    Taylor MJ
    Arch Med Res; 2002; 33(4):422-4. PubMed ID: 12234534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics which target the Wolbachia endosymbionts of filarial parasites: a new strategy for control of filariasis and amelioration of pathology.
    Pfarr KM; Hoerauf AM
    Mini Rev Med Chem; 2006 Feb; 6(2):203-10. PubMed ID: 16472187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corallopyronin A - a promising antibiotic for treatment of filariasis.
    Schäberle TF; Schiefer A; Schmitz A; König GM; Hoerauf A; Pfarr K
    Int J Med Microbiol; 2014 Jan; 304(1):72-8. PubMed ID: 24079981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model.
    Specht S; Pfarr KM; Arriens S; Hübner MP; Klarmann-Schulz U; Koschel M; Sternberg S; Martin C; Ford L; Taylor MJ; Hoerauf A
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006116. PubMed ID: 29300732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brugia pahangi and Wolbachia: the kinetics of bacteria elimination, worm viability, and host responses following tetracycline treatment.
    Chirgwin SR; Nowling JM; Coleman SU; Klei TR
    Exp Parasitol; 2003; 103(1-2):16-26. PubMed ID: 12810042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics for the treatment of onchocerciasis and other filarial infections.
    Hoerauf A; Adjei O; Büttner DW
    Curr Opin Investig Drugs; 2002 Apr; 3(4):533-7. PubMed ID: 12090719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.